KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $2.8 million.

  • Arbutus Biopharma's Prepaid Assets fell 1600.0% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of $2.3 million for FY2024, which is 4623.35% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Prepaid Assets stood at $2.8 million, which was down 1600.0% from $4.0 million recorded in Q2 2025.
  • Arbutus Biopharma's Prepaid Assets' 5-year high stood at $5.9 million during Q1 2022, with a 5-year trough of $2.3 million in Q4 2024.
  • Moreover, its 5-year median value for Prepaid Assets was $4.0 million (2025), whereas its average is $4.0 million.
  • As far as peak fluctuations go, Arbutus Biopharma's Prepaid Assets skyrocketed by 8573.53% in 2021, and later tumbled by 4623.35% in 2024.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Prepaid Assets stood at $4.4 million in 2021, then plummeted by 35.34% to $2.9 million in 2022, then surged by 47.81% to $4.2 million in 2023, then tumbled by 46.23% to $2.3 million in 2024, then rose by 24.12% to $2.8 million in 2025.
  • Its Prepaid Assets stands at $2.8 million for Q3 2025, versus $4.0 million for Q2 2025 and $2.9 million for Q1 2025.